Search
Selected: P

Prevention and treatment of amyloidogenic disease

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Prevention and treatment of amyloidogenic disease

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Prevention and treatment of amyloidogenic disease

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Prevention and treatment of amyloidogenic disease

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Prevention and treatment of amyloidogenic disease

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Prevention and treatment of amyloidogenic disease

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Prevention and treatment of amyloidogenic disease

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Prevention and treatment of retroviral disease

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Prevention and treatment of retroviral disease

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Prevention, diagnosis and treatment of lyme disease

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Preventive and therapeutic use of polypeptides from African...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Preventive and therapeutic use of polypeptides from African...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Primary biliary cirrhosis autoantigen and method of use

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Primate intra-acrosomal sperm antigen for use in a contraceptive

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Process for making human papillomavirus virus-like particles...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Process for the expression of herpes simplex virus type 1 glycop

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Process for the expression of herpes simplex virus type 1 glycop

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Process for the preparation of hypoallergenic mosaic antigens

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Product and process for liquefaction of mucus or sputum

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Production of recombinant protein pap 31 for the diagnosis...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.